An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

por Saavedra, Danay, Añé-Kourí, Ana Laura, Sánchez, Naivy, Filgueira, Lázaro Manuel, Betancourt, Julio, Herrera, Carlos, Manso, Leniel, Chávez, Elibet, Caballero, Armando, Hidalgo, Carlos, Lorenzo, Geydi, Cepeda, Meylan, Valenzuela, Carmen, Ramos, Mayra, León, Kalet, Mazorra, Zaima, Crombet, Tania
Publicado 2020

An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases

por Filgueira, Lázaro Manuel, Cervantes, Julio Betancourt, Lovelle, Orlando Adolfo, Herrera, Carlos, Figueredo, Carlos, Caballero, Jorge Alain, Sánchez, Naivy, Berrio, Jorge, Lorenzo, Geidy, Cepeda, Meylan, Ramos, Mayra, Saavedra, Danay, Añe-Kouri, Ana Laura, Mazorra, Zaima, Leon, Kalet, Crombet, Tania, Caballero, Armando
Publicado 2021